This inventor holds 6 USPTO granted patents. Top assignee: Ceskoslovenska Akademie Ved. Active years: 1976-1985.
Location History:
- Prague 4, CZ (1984)
- Prague, CZ (1976 - 1985)
Company Filing History:
Years Active: 1976-1985
Title: Karel Jost: Innovator in Neurohypophysial Hormones
Introduction
Karel Jost is a prominent inventor based in Prague, Czech Republic. He has made significant contributions to the field of neurohypophysial hormones, holding a total of 6 patents. His work focuses on the development of hormone analogs that exhibit inhibition effects, which have potential applications in various biological activities.
Latest Patents
Among his latest patents, Jost has developed analogs of neurohypophysial hormones with inhibition effects. One notable invention pertains to analogs characterized by the chemical formula I, where specific residues and groups are defined to demonstrate inhibition effects towards certain biological activities of neurohypophysial hormones. Another patent describes analogs that exhibit inhibition properties, featuring a common structural element of an aromatic hydrophobic D-amino acid in a specific position. These compounds are designed to inhibit uterotonic and pressor activities of natural hormones, showcasing Jost's innovative approach to hormone research.
Career Highlights
Karel Jost has dedicated his career to advancing the understanding of neurohypophysial hormones. His work at the Ceskoslovenska Akademie Ved has positioned him as a key figure in this specialized field. His research has not only contributed to scientific knowledge but also holds promise for therapeutic applications.
Collaborations
Throughout his career, Jost has collaborated with notable colleagues, including Tomislav Barth and Joseph H Cort. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Karel Jost's innovative work in the field of neurohypophysial hormones exemplifies the importance of research and development in advancing medical science. His contributions through patents and collaborations continue to influence the landscape of hormone research.
